Lv1
48 积分 2024-08-06 加入
A comparative study of the developability of full-length antibodies, fragments, and bispecific formats reveals higher stability risks for engineered constructs
6个月前
已完结
Enhanced rational protein engineering to reduce viscosity in high-concentration IgG1 antibody solutions
8个月前
已完结
Non-specificity as the sticky problem in therapeutic antibody development
1年前
已完结
Organic‐Solvent‐Free “Lego‐Like” Modular Preparation of Fab‐Nondestructive Antibody‐Drug Conjugates with Ultrahigh Drug‐to‐Antibody Ratio
1年前
已完结